• Fulcrum Therapeutics (FULC) Slides 3.7% as Sellers Test Key Support Near $3.45 - Charm Flow dars.gov.et Wed, 08 Jul 2026 16:34:20 GMT
• Fulcrum Therapeutics Inc. (FULC) Q1 2026 Earnings: Narrower-than-Expected Loss Drives Positive Market Reaction - Revenue Surprise ... dars.gov.et Sat, 04 Jul 2026 01:30:41 GMT
• Fulcrum Therapeutics (FULC) director awarded 32,000 options at $3.66 Stock Titan Thu, 02 Jul 2026 20:32:23 GMT
• Fulcrum Therapeutics (FULC) director receives 32,000 stock options at $3.66 strike Stock Titan Thu, 02 Jul 2026 20:32:20 GMT
• Fulcrum Therapeutics (FULC) director granted 32,000 stock options at $3.66 strike Stock Titan Thu, 02 Jul 2026 20:31:19 GMT
• [Form 4] Fulcrum Therapeutics, Inc. Insider Trading Activity Stock Titan Thu, 02 Jul 2026 20:31:11 GMT
• Fulcrum Therapeutics (FULC) director awarded options on 32,000 shares Stock Titan Thu, 02 Jul 2026 20:31:10 GMT
• fulcrum therapeutics (fulc) director receives stock options for 32,000 shares Stock Titan Thu, 02 Jul 2026 20:31:10 GMT
• after plunging 21.5% in 4 weeks, here's why the trend might reverse for fulcrum therapeutics (fulc) MSN Thu, 02 Jul 2026 19:48:58 GMT
• Insider Sell Alert: Alan Ezekowitz Sells 18,000 Shares of Fulcru GuruFocus Tue, 30 Jun 2026 23:10:59 GMT
• Fulcrum Therapeutics (FULC) director sells 18,000 shares under 10b5-1 plan Stock Titan Tue, 30 Jun 2026 07:00:00 GMT
• layoff tracker: biocryst ends all internal discovery efforts BioSpace Tue, 30 Jun 2026 07:00:00 GMT
• Fulcrum Therapeutics, Inc.(NasdaqGM:FULC) dropped from Russell 2500 Growth Benchmark marketscreener.com Mon, 29 Jun 2026 19:41:12 GMT
• Price to sales forward of Fulcrum Therapeutics, Inc. – NASDAQ:FULC TradingView Sun, 28 Jun 2026 23:29:00 GMT
• Fulcrum Therapeutics, Inc.(NasdaqGM:FULC) dropped from Russell Microcap Growth Benchmark Index marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• Fulcrum Therapeutics (FULC) Stock Fair Value Moves Lower After Pociredir Exit Yahoo Finance Sat, 27 Jun 2026 07:00:00 GMT
• fulcrum therapeutics, inc. actuals & estimates (nasdaq:fulc) TradingView Fri, 26 Jun 2026 09:16:11 GMT
• fierce biotech layoff tracker 2026: biocryst ends internal programs; biogen sheds apellis r&d roles Fierce Biotech Fri, 26 Jun 2026 07:00:00 GMT
• layoff tracker: biogen axes ‘small number’ of apellis roles after $5.6b buy BioSpace Fri, 26 Jun 2026 07:00:00 GMT
• fierce biotech layoff tracker 2026: biogen sheds apellis r&d roles; adc tx slims workforce Fierce Biotech Fri, 26 Jun 2026 07:00:00 GMT
• Fulcrum Therapeutics (FULC) details 2026 stockholder voting on directors and key proposals Stock Titan Thu, 25 Jun 2026 07:00:00 GMT
• EcoR1, Oleg Nodelman disclose 9.0% stake in Fulcrum (NASDAQ: FULC) Stock Titan Thu, 25 Jun 2026 07:00:00 GMT
• EcoR1 Capital (FULC) reports shared control of 6.0M shares; 9.0% stake Stock Titan Thu, 25 Jun 2026 07:00:00 GMT
• fulcrum therapeutics inc (fulc) valuation: pe, pb & fair value analysis TradingKey Wed, 24 Jun 2026 07:00:00 GMT
• fulcrum therapeutics inc (fulc) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 24 Jun 2026 07:00:00 GMT
• piper sandler downgrades fulcrum therapeutics(fulc.us) to sell rating, cuts target price to $3 富途牛牛 Tue, 23 Jun 2026 11:06:18 GMT
• fulcrum therapeutics, inc. (nasdaq: fulc) faces possible securiti The National Law Review Sat, 20 Jun 2026 23:01:47 GMT
• bronstein, gewirtz & grossman, llc initiates an investigation into allegations against fulcrum therapeutics, inc. (fulc) and encou... ACCESS Newswire Fri, 19 Jun 2026 19:18:29 GMT
• 2026-06-19 | bronstein, gewirtz & grossman, llc initiates an investigation into allegations against fulcrum therapeutics, inc. (fu... Stockhouse Fri, 19 Jun 2026 15:00:00 GMT
• bronstein, gewirtz & grossman, llc announces an investigation against fulcrum therapeutics, inc. (fulc) and encourages shareholder... ACCESS Newswire Fri, 19 Jun 2026 00:33:09 GMT
• fulcrum therapeutics inc (fulc) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 10:40:30 GMT
• Fulcrum Therapeutics Inc (FULC) Earnings Forecast: Future EPS & Revenue Growth Estimates TradingKey Thu, 18 Jun 2026 08:19:03 GMT
• fulcrum therapeutics inc (fulc) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 07:53:08 GMT
• investors of fulcrum therapeutics, inc. (nasdaq: fulc) are encouraged to contact kaplan fox regarding the investigation of potenti... The Globe and Mail Thu, 18 Jun 2026 07:00:00 GMT
• fulcrum therapeutics inc (fulc) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 06:08:38 GMT
• fulcrum therapeutics inc (fulc) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 01:18:23 GMT
• Kaplan Fox Reminds Investors of Fulcrum Therapeutics, Inc. (NASDAQ: FULC) to an Investigation of Potential Securities Law Violatio... NewMediaWire Wed, 17 Jun 2026 18:33:50 GMT
• Fulcrum Therapeutics, Inc. (FULC) Investigation: Bronstein, Gewir The National Law Review Wed, 17 Jun 2026 17:09:21 GMT
• fulcrum therapeutics inc (fulc) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 13:49:58 GMT
• fulcrum therapeutics inc (fulc) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 05:47:39 GMT
• bronstein, gewirtz & grossman, llc encourages fulcrum therapeutics, inc. (fulc) shareholders to inquire about securities investiga... ACCESS Newswire Wed, 17 Jun 2026 00:36:37 GMT
• fulcrum therapeutics investors are encouraged to contact kaplan fox & kilsheimer llp regarding potential securities law violations... NewMediaWire Tue, 16 Jun 2026 16:43:22 GMT
• fierce biotech layoff tracker 2026: engene halves workforce; neumora cuts 35% Fierce Biotech Tue, 16 Jun 2026 07:00:00 GMT
• layoff tracker: neumora, engene cut staff in cost-saving initiatives BioSpace Tue, 16 Jun 2026 07:00:00 GMT
• fulcrum therapeutics inc (fulc) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• fulcrum therapeutics, inc. (fulc) investigation: bronstein, gewirtz & grossman, llc encourages shareholders to contact the firm to... ACCESS Newswire Mon, 15 Jun 2026 17:32:37 GMT
• 2026-06-15 | fulcrum therapeutics, inc. (fulc) investigation: bronstein, gewirtz & grossman, llc encourages shareholders to contac... Stockhouse Mon, 15 Jun 2026 15:00:00 GMT
• bronstein, gewirtz & grossman, llc is investigating fulcrum therapeutics, inc. (fulc) and encourages investors to connect ACCESS Newswire Sun, 14 Jun 2026 18:51:06 GMT
• bronstein, gewirtz & grossman, llc encourages fulcrum therapeutics, inc. (fulc) stockholders to inquire about securities investiga... ACCESS Newswire Fri, 12 Jun 2026 16:48:20 GMT
• fulcrum therapeutics, inc. files form 8-k report with sec – company information and key details (june 2026) Minichart Fri, 12 Jun 2026 13:08:00 GMT
• fulcrum therapeutics, inc. announces departure of greg tourangeau, principal accounting officer marketscreener.com Thu, 11 Jun 2026 20:30:00 GMT
• bronstein, gewirtz & grossman, llc announces an investigation against fulcrum therapeutics, inc. (fulc) and encourages investors t... ACCESS Newswire Thu, 11 Jun 2026 15:52:44 GMT
• Cambridge biotech laying off 85% of workforce after FDA halts drug for cancer risks MassLive Thu, 11 Jun 2026 07:00:00 GMT
• Fulcrum Therapeutics (NASDAQ: FULC) adds change-in-control pay, finance chief to depart Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• fierce biotech layoff tracker 2026: genentech trims r&d; fulcrum shrinks headcount 85% Fierce Biotech Thu, 11 Jun 2026 07:00:00 GMT
• fulc stock crashes as cancer risk forces its only drug program's end MSN Wed, 10 Jun 2026 19:23:04 GMT
• fulcrum therapeutics, inc. (fulc) investigation: bronstein, gewirtz & grossman, llc encourages shareholders to contact the firm to... ACCESS Newswire Wed, 10 Jun 2026 16:42:42 GMT
• kaplan fox is investigating potential securities law violations against fulcrum therapeutics, inc. (nasdaq: fulc) NewMediaWire Wed, 10 Jun 2026 07:00:00 GMT
• tang entities report 5,451,800‑share stake in fulcrum (fulc) Stock Titan Wed, 10 Jun 2026 07:00:00 GMT
• fulcrum therapeutics, inc. (fulc) investigation: bronstein, gewirtz & grossman, llc encourages stockholders to contact the firm to... ACCESS Newswire Tue, 09 Jun 2026 19:18:06 GMT
• investors of fulcrum therapeutics, inc. (nasdaq: fulc) are encouraged to contact kaplan fox regarding the investigation of potenti... NewMediaWire Tue, 09 Jun 2026 13:31:39 GMT
• Fulcrum Therapeutics, Inc. (FULC) Securities Fraud Investigation - Levi & Korsinsky PR Newswire Tue, 09 Jun 2026 07:00:00 GMT
• Cambridge biotech surrenders half its lab space amid cash crunch The Business Journals Tue, 09 Jun 2026 07:00:00 GMT
• bronstein, gewirtz & grossman, llc announces an investigation against fulcrum therapeutics, inc. (fulc) and encourages stockholder... ACCESS Newswire Mon, 08 Jun 2026 15:49:17 GMT
• Kaplan Fox is Investigating Fulcrum Therapeutics, Inc. (NASDAQ: FULC) for Potential Securities Law Violations NewMediaWire Mon, 08 Jun 2026 07:00:00 GMT
• layoff tracker: fulcrum axes 85% of staff after walking away from lead asset BioSpace Mon, 08 Jun 2026 07:00:00 GMT
• fulc stock crashes as cancer risk forces its only drug program's end MSN Mon, 08 Jun 2026 01:17:53 GMT
• bronstein, gewirtz & grossman, llc encourages fulcrum therapeutics, inc. (fulc) investors to inquire about securities investigatio... ACCESS Newswire Sun, 07 Jun 2026 16:12:00 GMT
• fulc stock crashes as cancer risk forces its only drug program's end MSN Sun, 07 Jun 2026 11:28:23 GMT
• kaplan fox encourages investors of fulcrum therapeutics, inc. (na The National Law Review Fri, 05 Jun 2026 20:33:58 GMT
• bronstein, gewirtz & grossman, llc initiates an investigation into allegations against fulcrum therapeutics, inc. (fulc) and encou... ACCESS Newswire Fri, 05 Jun 2026 16:10:20 GMT
• Fulcrum lays off 85% of staff after dropping asset, leaving 9 employees BioSpace Fri, 05 Jun 2026 07:00:00 GMT
• A Look At Fulcrum Therapeutics (FULC) Valuation After Scrapping Lead Sickle Cell Drug And Restructuring Yahoo Finance Fri, 05 Jun 2026 07:00:00 GMT
• Fulcrum Therapeutics (FULC) Loses 51% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner Yahoo Finance Fri, 05 Jun 2026 07:00:00 GMT
• Levi & Korsinsky Announces Investigation of Securities Claims Against Fulcrum Therapeutics, Inc. (FULC) GlobeNewswire Fri, 05 Jun 2026 07:00:00 GMT
• Fulcrum Therapeutics lays off 85% of workforce as it seeks strategic alternatives The Business Journals Fri, 05 Jun 2026 07:00:00 GMT
• Fulcrum lays off majority of staff; Seres extends runway into 2027 Endpoints News Fri, 05 Jun 2026 07:00:00 GMT
• biopharma bites: white house reportedly mulling sharpless to lead fda, plus fulcrum's layoffs and more from innocare, chiesi FirstWord Pharma Fri, 05 Jun 2026 07:00:00 GMT
• fierce biotech layoff tracker 2026: fulcrum cuts 85% of staff; novartis trims research team Fierce Biotech Fri, 05 Jun 2026 07:00:00 GMT
• fulc stock slumps nearly 50% after hours as fda kills only clinical program over cancer risk Stocktwits Fri, 05 Jun 2026 03:36:00 GMT
• fulcrum therapeutics undertakes major restructuring, explores strategic alternatives TipRanks Thu, 04 Jun 2026 21:22:05 GMT
• Fulcrum Therapeutics (FULC) cuts workforce 85% and hires Leerink for strategic review Stock Titan Thu, 04 Jun 2026 07:00:00 GMT
• Fulcrum scraps sickle cell drug after FDA raises safety concerns Sickle Cell Disease News Thu, 04 Jun 2026 07:00:00 GMT
• FULC Investor Alert: Levi & Korsinsky Investigates Fulcrum Therapeutics, Inc. (FULC) for Potential Securities Fraud Business Wire Thu, 04 Jun 2026 07:00:00 GMT
• What's Going On With Fulcrum Therapeutics Stock On Thursday? Benzinga Thu, 04 Jun 2026 07:00:00 GMT
• A Look At Fulcrum Therapeutics (FULC) Valuation After Halting Pociredir And Launching A Broad Review simplywall.st Thu, 04 Jun 2026 07:00:00 GMT
• fulcrum therapeutics to cut most of staff after ending sickle-cell-drug development Moomoo Thu, 04 Jun 2026 07:00:00 GMT
• fulcrum therapeutics, inc. approves restructuring plan marketscreener.com Thu, 04 Jun 2026 07:00:00 GMT
• fulcrum therapeutics, inc. engages leerink partners llc as financial advisor to assist in reviewing potential strategic alternativ... marketscreener.com Thu, 04 Jun 2026 07:00:00 GMT
• fulc downgraded by jp morgan -- rating changed to underweight GuruFocus Thu, 04 Jun 2026 02:03:25 GMT
• j.p. morgan downgrades fulcrum therapeutics(fulc.us) to sell rating 富途牛牛 Wed, 03 Jun 2026 19:54:03 GMT
• safety concern ends fulcrum program, most other prc2 drug development continues Citeline News & Insights Wed, 03 Jun 2026 18:21:49 GMT
• fulc downgraded by jp morgan -- rating changed to underweight GuruFocus Wed, 03 Jun 2026 16:24:38 GMT
• FULC Stock Crashes as Cancer Risk Forces Its Only Drug Program's End Yahoo Finance Wed, 03 Jun 2026 07:00:00 GMT
• FULC SHAREHOLDER INVESTIGATION: SueWallSt Investigates Fulcrum Therapeutics, Inc. for Possible Securities Law Violations PR Newswire Wed, 03 Jun 2026 07:00:00 GMT
• Why Fulcrum Therapeutics (FULC) Is Down 53.6% After Ending Pociredir And Exploring Strategic Options simplywall.st Wed, 03 Jun 2026 07:00:00 GMT
• Fulcrum: 'Hold' On Pociredir Discontinuation And Strategic Alternatives Shift Seeking Alpha Wed, 03 Jun 2026 07:00:00 GMT
• This Truist Securities Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday Benzinga Wed, 03 Jun 2026 07:00:00 GMT
• jpmorgan downgrades fulcrum therapeutics to underweight from overweight marketscreener.com Wed, 03 Jun 2026 07:00:00 GMT
• why is fulcrum therapeutics stock collapsing today? by investing.com Investing.com Australia Wed, 03 Jun 2026 07:00:00 GMT
• fulc downgraded by stifel -- price target lowered to $3.00 GuruFocus Wed, 03 Jun 2026 00:27:38 GMT
• goldman sachs drops fulcrum therapeutics stock coverage after trial halt Investing.com UK Wed, 03 Jun 2026 00:21:15 GMT
• goldman sachs suspends rating on fulcrum therapeutics (fulc) GuruFocus Wed, 03 Jun 2026 00:00:00 GMT
• bofa securities maintains fulcrum therapeutics(fulc.us) with sell rating, cuts target price to $3 富途牛牛 Tue, 02 Jun 2026 23:08:26 GMT
• goldman sachs drop coverage of fulcrum therapeutics inc. (fulc) StreetInsider Tue, 02 Jun 2026 20:27:53 GMT
• fulc downgraded by piper sandler - price target lowered to $3.00 GuruFocus Tue, 02 Jun 2026 18:26:45 GMT
• fulcrum therapeutics (fulc) faces significant pre-market decline GuruFocus Tue, 02 Jun 2026 14:48:45 GMT
• this biotech stock plunges 52%. its sickle cell drug has 'no viable path forward.' MSN Tue, 02 Jun 2026 13:51:54 GMT
• this biotech stock plunges 48%. its sickle cell drug has 'no viable path forward.' MSN Tue, 02 Jun 2026 12:50:05 GMT
• fulcrum tanks as cancer concerns stymie sickle cell asset, trigger business reorg BioSpace Tue, 02 Jun 2026 12:23:37 GMT
• stifel downgrades fulcrum therapeutics to hold from buy, adjusts pt to $3 from $25 marketscreener.com Tue, 02 Jun 2026 11:32:35 GMT
• hc wainwright downgrades fulcrum therapeutics to neutral from buy, adjusts pt to $3 from $25 marketscreener.com Tue, 02 Jun 2026 10:47:34 GMT
• Fulcrum scraps SCD program, considers options after FDA takes hard line on safety risks Fierce Biotech Tue, 02 Jun 2026 07:00:00 GMT
• Fulcrum plummets over 50% after scrapping lead sickle-cell drug on FDA concerns Reuters Tue, 02 Jun 2026 07:00:00 GMT
• Fulcrum exploring a potential sale after FDA sidelined its sickle cell drug BioPharma Dive Tue, 02 Jun 2026 07:00:00 GMT
• Fulcrum Therapeutics, Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Fulcrum Therapeuti... PR Newswire Tue, 02 Jun 2026 07:00:00 GMT
• This Biotech Stock Plunges 54%. Its Sickle Cell Drug Has ‘No Viable Path Forward.’ Barron's Tue, 02 Jun 2026 07:00:00 GMT
• FDA Concerns About Cancer Risk Sink Fulcrum Therapeutics’ Sickle Cell Disease Drug MedCity News Tue, 02 Jun 2026 07:00:00 GMT
• Fulcrum drops work on SCD drug pociredir; stock plummets BioWorld News Tue, 02 Jun 2026 07:00:00 GMT
• FULC INVESTOR ALERT: Holzer & Holzer, LLC Investigation of Fulcrum Therapeutics, Inc. GlobeNewswire Tue, 02 Jun 2026 07:00:00 GMT
• Fulcrum Therapeutics (FULC) Faces Downgrade Amid Development Hal GuruFocus Tue, 02 Jun 2026 07:00:00 GMT
• Fulcrum Therapeutics Halts Sickle Cell Drug Development Following Cancer Risk Concerns geneonline.com Tue, 02 Jun 2026 07:00:00 GMT
• Fulcrum Therapeutics (FULC) Halts Sickle Cell Drug Development, Stock Plummets GuruFocus Tue, 02 Jun 2026 07:00:00 GMT
• Goldman Sachs drops Fulcrum Therapeutics stock coverage after trial halt Investing.com Tue, 02 Jun 2026 07:00:00 GMT
• Ten-year-old Cambridge biotech in market for merger, acquisition The Business Journals Tue, 02 Jun 2026 07:00:00 GMT
• Fulcrum falls after dropping lead program (FULC:NASDAQ) Seeking Alpha Tue, 02 Jun 2026 07:00:00 GMT
• Goldman Sachs Suspends Rating on Fulcrum Therapeutics (FULC) GuruFocus Tue, 02 Jun 2026 07:00:00 GMT
• Fulcrum Therapeutics, Inc. Shareholders Are Encouraged to GlobeNewswire Tue, 02 Jun 2026 07:00:00 GMT
• Fulcrum plummets 50% after scrapping lead sickle-cell drug on FDA concerns Yahoo Finance Tue, 02 Jun 2026 07:00:00 GMT
• Fulcrum ends sickle cell ambitions following regulatory feedback, will seek exit Endpoints News Tue, 02 Jun 2026 07:00:00 GMT
• Fulcrum Therapeutics Announces Discontinuation of Pociredir Program in Sickle Cell Disease and Initiation of Strategic Review The Manila Times Tue, 02 Jun 2026 07:00:00 GMT
• Fulcrum scraps sickle cell drug program after FDA raises cancer-risk concerns ETPharma.com Tue, 02 Jun 2026 07:00:00 GMT
Fulcrum Therapeutics, Inc(NASDAQ:FULC) 
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule that is i...
Website: http://www.fulcrumtx.com
Founded: 2015
Full Time Employees: 73
CEO: Robert J. Gould
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends